MedPath

Dissociable behavioral and neurophysiological mediators of cognitive behavioral therapy (CBT) and high intensity interval training (HIIT) success in cannabis use disorder

Not Applicable
Conditions
Cannabis Use Disorder (DSM-V)
Registration Number
DRKS00034219
Lead Sponsor
Charité - Universitätsmedizin Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
219
Inclusion Criteria

Diagnosed cannabis use disorder (DSM-V)

Exclusion Criteria

Acute (hypo-)manic episode remitted for less than 4 weeks
Depressive episode remitted for less than 4 weeks
Psychopharmacological treatment of bipolar disorder/ depressive episode less than 2 weeks stable
Schizophrenia/ psychotic episode: fully remitted for less than 4 weeks
Current psychotherapeutic or addiction-specific treatment (without possible break during the study)
Taking sedatives/ neuroleptics
Current other substance use disorder apart from nicotine & cannabis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pupil size (Pupil Labs; objective and continuous measure)<br>Skin conductance (PsychLab; objective and continuous measure)<br>Heart rate (PsychLab; objective and continuous measure)<br>Oxytocin reactivity (Salivette®; objective and continuous measure)<br>Cannabis abstinence (Drug-Screen® Multi 7 Test; objective and categorical measure)<br>Consumption reduction (Form-90 interview; subjective and continuous measure)
Secondary Outcome Measures
NameTimeMethod
Depressiveness (BDI-II; Beck et al., 1996)<br>(Social) Anxiety (LSAS; Liebowitz, 1987 and GAD-7; Spitzer et al., 2006)<br>Physical activity (IPAQ; Craig et al., 2003)<br>State of health (SF-12; Ware et al., 1996)
© Copyright 2025. All Rights Reserved by MedPath